Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
01 Outubro 2024 - 5:19PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2024
Commission File Number 001-39124
Centogene N.V.
(Translation of registrant's name into English)
Am Strande
7
18055 Rostock
Germany
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form
40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Centogene N.V.
Supervisory Board Matters
Centogene N.V. (the “Company”)
previously announced the resignation of Peer Schatz, Mary Sheahan and Jonathan Sheldon from the Supervisory Board of the Company (the
“Supervisory Board”) effective as of September 30, 2024. Mr. Schatz and Ms. Sheahan have since each notified the Company
that they will defer the effective date of their respective resignations from the Supervisory Board to October 15, 2024. The Supervisory
Board has approved each such deferral.
Signatures
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: October 1, 2024 |
|
|
|
CENTOGENE N.V. |
|
|
By: |
/s/ Peter Bauer |
|
|
Name: |
Peter Bauer |
|
|
Title: |
Chief Medical & Genomic Officer |
Centogene NV (QB) (USOTC:CNTGF)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Centogene NV (QB) (USOTC:CNTGF)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
Notícias em tempo-real sobre Centogene NV (QB) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Centogene NV (PK)